Titan Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
TTNP Titan Pharmaceuticals Inc
AEP American Electric Power Company Inc
BAF BlackRock Municipal Income Investment Quality Trust
HRTH Harte Hanks Inc
STRA Strategic Education Inc
TFECY Thin Film Electronics ASA
ELY Callaway Golf Co
WBA Walgreens Boots Alliance Inc
GOOG Alphabet Inc
CUB Cubic Corp
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Titan Pharmaceuticals, Inc. (Titan) is a specialty pharmaceutical company. The Company is engaged in developing therapeutics for the treatment of medical disorders. The Company's segment is engaged in the development of pharmaceutical products. The Company's product development programs utilize its long-term drug delivery platform, ProNeura. The Company's drug candidate, Probuphine, is being developed for the long-term maintenance treatment of opioid dependence. Titan's ProNeura continuous drug delivery system consists of a small, solid rod made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The Company focuses on developing two product development programs, the first one with a ropinirole implant for the treatment of Parkinson's disease (PD) and the second one with a Triiodothyronine (T3) implant for the treatment of hypothyroidism.

Closing Price
$0.1899
Day's Change
0.0234 (14.05%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.2144
Day's Low
0.156
Volume
(Average)
Volume:
118,413,202

10-day average volume:
114,348,401
118,413,202

Display:

Providers:

UpdateCancel
6 providers

No news found.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.